Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ランチオニンシンテターゼC様2系治療薬
Document Type and Number:
Japanese Patent JP6499306
Kind Code:
B2
Abstract:
Provided are compositions comprising a compound of the formula shown below that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infection disease, autoimmune disease, diabetes, and a chronic inflammatory disease.or a pharmaceutically acceptable salt thereof

Inventors:
Basaganya-Lierra Josep
Carbo Barrios Adria
Gandor Richard
Cooper Julian Dee
Hongtesilas Raquel
Application Number:
JP2017540961A
Publication Date:
April 10, 2019
Filing Date:
March 19, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Lands by Offermine Inc.
International Classes:
C07D235/18; A61K31/4184; A61K31/423; A61K31/4439; A61K31/496; A61P1/04; A61P3/10; A61P29/00; A61P31/00; A61P31/12; A61P31/16; A61P37/06; C07D263/62; C07D401/04; C07D401/14; C07D413/04; C07D413/14
Foreign References:
WO2005082905A1
US20110275558
Other References:
HACER KARATAS,SYNTHESIS AND POTENT IN VITRO ACTIVITY OF NOVEL 1H-BENZIMIDAZOLES AS ANTI-MRSA AGENTS,CHEMICAL BIOLOGY & DRUG DESIGN,BLACKWELL MUNKSGAARD,2012年 4月30日,VOL:80, NR:2,,PAGE(S):237 - 244,URL,http://dx.doi.org/10.1111/j.1747-0285.2012.01393.x
LUO Y,SYNTHESIS AND IN VITRO CYTOTOXIC EVALUATION OF SOME THIAZOLYLBENZIMIDAZOLE DERIVATIVES,EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,フランス,EDITIONS SCIENTIFIQUE ELSEVIER,2011年,VOL:46, NR:1,,PAGE(S):417 - 422,URL,http://dx.doi.org/10.1016/j.ejmech.2010.11.014
Attorney, Agent or Firm:
Shinichiro Tanaka
Disciple Maru Ken
▲吉▼田 和彦
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori